Literature DB >> 21637185

Update: influenza activity--United States, 2010-11 season, and composition of the 2011-12 influenza vaccine.

.   

Abstract

During the 2010-11 influenza season, influenza activity* first began to increase in the southeastern United States, and peaked nationally in early February. Compared with the previous pandemic year (2009-10), higher rates of hospitalization were observed for persons aged≥65 years during the 2010-11 season, whereas lower hospitalization rates were observed in younger populations than during the pandemic year. Overall, the percentages of outpatient visits for influenza-like illness (ILI) were lower during the 2010-11 season than the 2009-10 pandemic influenza season. In the United States, influenza A (H3N2) remained the predominant virus throughout the season; however, 2009 influenza A (H1N1) and influenza B viruses also circulated, and the predominant virus varied by U.S. Department of Health and Human Service (HHS) region and week. This report summarizes influenza activity in the United States during the 2010-11 influenza season (October 3, 2010-May 21, 2011) and describes the components of the 2011-12 Northern Hemisphere influenza vaccine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21637185

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  40 in total

1.  Pandemic and seasonal human influenza virus infections in domestic cats: prevalence, association with respiratory disease, and seasonality patterns.

Authors:  A Ali; J B Daniels; Y Zhang; A Rodriguez-Palacios; K Hayes-Ozello; L Mathes; C-W Lee
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

2.  Subtyping clinical specimens of influenza A virus by use of a simple method to amplify RNA targets.

Authors:  Jingjing Wang; Warren Tai; Stephanie L Angione; Amrita R John; Steven M Opal; Andrew W Artenstein; Anubhav Tripathi
Journal:  J Clin Microbiol       Date:  2013-07-31       Impact factor: 5.948

3.  Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans.

Authors:  Puja Van Epps; Terrence Tumpey; Melissa B Pearce; Hana Golding; Patricia Higgins; Thomas Hornick; Christopher Burant; Brigid M Wilson; Richard Banks; Stefan Gravenstein; David H Canaday
Journal:  Clin Vaccine Immunol       Date:  2017-03-06

Review 4.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

5.  The Effectiveness of Trivalent Inactivated Influenza Vaccine in Children with Acute Leukemia.

Authors:  April Sykes; Elsie Gerhardt; Li Tang; Elisabeth E Adderson
Journal:  J Pediatr       Date:  2017-12       Impact factor: 4.406

6.  Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease.

Authors:  J Bradley Layton; Leah J McGrath; John M Sahrmann; Yinjiao Ma; Vikas R Dharnidharka; Caroline O'Neil; David J Weber; Anne M Butler
Journal:  Vaccine       Date:  2020-06-19       Impact factor: 3.641

7.  Assessment of Virus Interference in a Test-negative Study of Influenza Vaccine Effectiveness.

Authors:  Shuo Feng; Ashley L Fowlkes; Andrea Steffens; Lyn Finelli; Benjamin J Cowling
Journal:  Epidemiology       Date:  2017-07       Impact factor: 4.822

8.  Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Receiving Maintenance Hemodialysis.

Authors:  Anne M Butler; J Bradley Layton; Vikas R Dharnidharka; John M Sahrmann; Marissa J Seamans; David J Weber; Leah J McGrath
Journal:  Am J Kidney Dis       Date:  2019-08-01       Impact factor: 8.860

9.  Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States.

Authors:  Benjamin J Cowling; Shuo Feng; Lyn Finelli; Andrea Steffens; Ashley Fowlkes
Journal:  Vaccine       Date:  2015-11-21       Impact factor: 3.641

10.  Influenza Vaccine is Protective Against Laboratory-confirmed Influenza in Obese Children.

Authors:  Michael A Smit; Hai-Lin Wang; Edward Kim; Noel Barragan; Grace M Aldrovandi; Alvin Nelson El Amin; Laurene Mascola; Pia S Pannaraj
Journal:  Pediatr Infect Dis J       Date:  2016-04       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.